Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Thomas B. Cooper, MA
JCP
Letter to the Editor
Rapastinel (GLYX-13) Effects in OCD
February 21, 2018
Read a study investigating the effects of rapastinel administration on 7 patients with OCD.
Omer Linkovski
,
Hanyang Shen
,
Jordana Zwerling
, et al
JCP
Original Research
Omega-3 Polyunsaturated Fatty Acid (PUFA) Status in Major Depressive Disorder With Comorbid Anxiety Disorders
July 15, 2013
Joanne J. Liu
,
Hanga C. Galfalvy
,
Thomas B. Cooper
, et al
JCP
Original Research
Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia
April 1, 2004
Jean-Pierre Lindenmayer
,
Pal Czobor
,
Jan Volavka
, et al
JCP
Original Research
Prolactin Levels in Schizophrenia and Schizoaffective Disorder Patients Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol
January 1, 2004
Jan Volavka
,
Pal Czobor
,
Thomas B. Cooper
, et al
